YAP/TAZ dephosphorylation and overexpression increased in trastuzumab-resistant breast cancer cells, suggesting that the dysregulated Hippo pathway further facilitated cancer cells in coordination with HER2 [127]. Here, YAP1 is linked to breast cancer.